Chemokine-Releasing nanoparticles for manipulation of the lymph node microenvironment

Nanomaterials

Volumn 5, Issue 1, 2014, Pages 298-320

  Popova, Taissia G ^a   Teunis, Allison ^a   Magni, Ruben ^a   Luchini, Alessandra ^a   Espina, Virginia ^a   Liotta, Lance A ^a   Popov, Serguei G ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

Chemokines; Lymph node; Nanoparticles; Neutrophils

Indexed keywords

EID: 84940451913     PISSN: None     EISSN: 20794991     Source Type: Journal    
DOI: 10.3390/nano5010298     Document Type: Article

References (62)

1. Sadik, C.D.; Luster, A.D. Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation. J. Leukoc. Biol. 2012, 91, 207-215.
2. Kelly, M.; Hwang, J.M.; Kubes, P. Modulating leukocyte recruitment in inflammation. J. Allergy Clin. Immunol. 2007, 120, 3-10.
3. Godaly, G.; Bergsten, G.; Hang, L.; Fischer, H.; Frendéus, B.; Lundstedt, A.C.; Samuelsson, M.; Samuelsson, P.; Svanborg, C. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukoc. Biol. 2001, 69, 899-906.
4. Liston, A.; McColl, S. Subversion of the chemokine world by microbial pathogens. BioEssays 2003, 25, 478-488.
5. Hiroshi Kohara, Y.T. Review: Tissue engineering technology to enhance cell recruitment for regeneration therapy. J. Med. Biol. Eng. 2010, 30, 267-276.
6. Houshmand, P.; Zlotnik, A. Therapeutic applications in the chemokine superfamily. Curr. Opin. Chem. Biol. 2003, 7, 457-460.
7. Balmert, S.C.; Little, S.R. Biomimetic delivery with micro- and nanoparticles. Adv. Mater. 2012, 24, 3757-3778.
8. Wang, Y.; Irvine, D.J. Engineering chemoattractant gradients using chemokine-releasing polysaccharide microspheres. Biomaterials 2011, 32, 4903-4913.
9. Zhao, X.; Jain, S.; Benjamin Larman, H.; Gonzalez, S.; Irvine, D.J. Directed cell migration via chemoattractants released from degradable microspheres. Biomaterials 2005, 26, 5048-5063.
10. Kumamoto, T.; Huang, E.K.; Paek, H.J.; Morita, A.; Matsue, H.; Valentini, R.F.; Takashima, A. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat. Biotechnol. 2002, 20, 64-69.
11. Singh, A.; Suri, S.; Roy, K. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. Biomaterials 2009, 30, 5187-200.
12. Kress, H.; Park, J.-G.; Mejean, C.O.; Forster, J.D.; Park, J.; Walse, S.S.; Zhang, Y.; Wu, D.; Weiner, O.D.; Fahmy, T.M.; et al. Cell stimulation with optically manipulated microsources. Nat. Methods 2009, 6, 905-909.
13. Cross, D.P.; Wang, C. Stromal-derived factor-1 alpha-loaded PLGA microspheres for stem cell recruitment. Pharm. Res. 2011, 28, 2477-2489.
14. Kuraitis, D.; Zhang, P.; Zhang, Y.; Padavan, D.T.; McEwan, K.; Sofrenovic, T.; McKee, D.; Zhang, J.; Griffith, M.; Cao, X.; et al. A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur. Cell. Mater. 2011, 22, 109-123.
15. Zhang, G.; Nakamura, Y.; Wang, X.; Hu, Q.; Suggs, L.J.; Zhang, J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng. 2007, 13, 2063-2071.
16. Van de Weert, M.; Hennink, W.E.; Jiskoot, W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 2000, 17, 1159-1167.
17. Zhu, G.; Mallery, S.R.; Schwendeman, S.P. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat. Biotechnol. 2000, 18, 52-57.
18. Luchini, A.; Geho, D.H.; Bishops, B.; Tran, D.; Xia, C.; Dufour, R.L.; Jones, C.D.; Espina, V.; Patanarut, A.; Zhou, W.; et al. Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation. Nano Lett. 2008, 8, 350-361.
19. Longo, C.; Patanarut, A.; George, T.; Bishop, B.; Zhou, W.; Fredolini, C.; Ross, M.M.; Espina, V.; Pellacani, G.; Petricoin, E.F.; et al. Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PLoS One 2009, 4, e4763.
20. Luchini, A.; Fredolini, C.; Espina, B.H.; Meani, F.; Reeder, A.; Rucker, S.; Petricoin, E.F.; Liotta, L.A. Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery. Curr. Mol. Med. 2010, 10, 133-141.
21. Tamburro, D.; Fredolini, C.; Espina, V.; Douglas, T.A.; Ranganathan, A.; Ilag, L.; Zhou, W.; Russo, P.; Espina, B.H.; Muto, G.; et al. Multifunctional core-shell nanoparticles: Discovery of previously invisible biomarkers. J. Am. Chem. Soc. 2011, 133, 19178-19188.
22. Longo, C.; Gambara, G.; Espina, V.; Luchini, A.; Bishop, B.; Patanarut, A.S.; Petricoin, E.F.; Beretti, F.; Ferrari, B.; Garaci, E.; et al. A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum. Exp. Dermatol. 2011, 20, 29-34.
23. Douglas, T.A.; Tamburro, D.; Fredolini, C.; Espina, B.H.; Lepene, B.S.; Ilag, L.; Espina, V.; Petricoin, E.F.; Liotta, L.A.; Luchini, A. The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. Biomaterials 2011, 32, 1157-1166.
24. Luchini, A.; Tamburro, D.; Magni, R.; Fredolini, C.; Espina, V.; Bosch, J.; Garaci, E.; Petricoin, E.F.; Liotta, L. Application of analyte harvesting nanoparticle technology to the measurement of urinary HGH in healthy individuals. J. Sports Med. Doping Stud. 2012, 2, 2-4.
25. Bosch, J.; Luchini, A.; Pichini, S.; Tamburro, D.; Fredolini, C.; Liotta, L.; Petricoin, E.; Pacifici, R.; Facchiano, F.; Segura, J.; et al. Analysis of urinary human growth hormone (HGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant HGH treatment: Preliminary results. J. Pharm. Biomed. Anal. 2013, 85, 194-197.
26. Magni, R.; Espina, B.H.; Liotta, L.A.; Luchini, A.; Espina, V. Hydrogel nanoparticle harvesting of plasma or urine for detecting low abundance proteins. J. Vis. Exp. 2014, e51789.
27. Castro-Sesquen, Y.E.; Gilman, R.H.; Galdos-Cardenas, G.; Ferrufino, L.; Sánchez, G.; Valencia Ayala, E.; Liotta, L.; Bern, C.; Luchini, A. Use of a novel chagas urine nanoparticle test (Chunap) for diagnosis of congenital chagas disease. PLoS Negl. Trop. Dis. 2014, 8, e3211.
28. Shafagati, N.; Patanarut, A.; Luchini, A.; Lundberg, L.; Bailey, C.; Petricoin, E.; Liotta, L.; Narayanan, A.; Lepene, B.; Kehn-Hall, K. The use of nanotrap particles for biodefense and emerging infectious disease diagnostics. Pathog. Dis. 2014, 71, 164-176.
29. Wenger, Y.; Schneider, R.J.; Reddy, G.R.; Kopelman, R.; Jolliet, O.; Philbert, M.A. Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. Toxicol. Appl. Pharmacol. 2011, 251, 181-190.
30. Lemperle, G.; Morhenn, V.; Charrier, U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet. Plast. Surg. 2003, 27, 354-366.
31. Gao, D.; Xu, H.; Philbert, M.A.; Kopelman, R. Bioeliminable nanohydrogels for drug delivery. Nano Lett. 2008, 8, 3320-3324.
32. Kumar, S.; Punekar, N.S. High-throughput screening of dye-ligands for chromatography. Methods Mol. Biol. 2014, 1129, 53-65.
33. Denizli, A.; Pişkin, E. Dye-ligand affinity systems. J. Biochem. Biophys. Methods 2001, 49, 391-416.
34. Sereikaite, J.; Bumelis, V.A. Examination of dye-protein interaction by gel-permeation chromatography. Biomed. Chromatogr. 2006, 20, 195-199.
35. Proudfoot, A.E.I.; Handel, T.M.; Johnson, Z.; Lau, E.K.; LiWang, P.; Clark-Lewis, I.; Borlat, F.; Wells, T.N.C.; Kosco-Vilbois, M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 2003, 100, 1885-1890.
36. Al-Alwan, L.A.; Chang, Y.; Mogas, A.; Halayko, A.J.; Baglole, C.J.; Martin, J.G.; Rousseau, S.; Eidelman, D.H.; Hamid, Q. Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration. J. Immunol. 2013, 191, 2731-2741.
37. Dennis, M.S.; Zhang, M.; Meng, Y.G.; Kadkhodayan, M.; Kirchhofer, D.; Combs, D.; Damico, L.A. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J. Biol. Chem. 2002, 277, 35035-35043.
38. Böhme, U.; Scheler, U. Effective charge of bovine serum albumin determined by electrophoresis NMR. Chem. Phys. Lett. 2007, 435, 342-345.
39. Manolova, V.; Flace, A.; Bauer, M.; Schwarz, K.; Saudan, P.; Bachmann, M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 2008, 38, 1404-1413.
40. Das, S.T.; Rajagopalan, L.; Guerrero-Plata, A.; Sai, J.; Richmond, A.; Garofalo, R.P.; Rajarathnam, K. Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS One 2010, 5, e11754.
41. Baggiolini, M.; Walz, A.; Kunkel, S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Investig. 1989, 84, 1045-1049.
42. Ramos, C.D.L.; Canetti, C.; Souto, J.T.; Silva, J.S.; Hogaboam, C.M.; Ferreira, S.H.; Cunha, F.Q. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J. Leukoc. Biol. 2005, 78, 167-177.
43. Yang, C.-W.; Strong, B.S.I.; Miller, M.J.; Unanue, E.R. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 2010, 185, 2927-2934.
44. Yang, C.-W.; Unanue, E.R. Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process. J. Exp. Med. 2013, 210, 375-387.
45. Massena, S.; Christoffersson, G.; Hjertström, E.; Zcharia, E.; Vlodavsky, I.; Ausmees, N.; Rolny, C.; Li, J.P.; Phillipson, M. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood 2010, 116, 1924-1931.
46. Kuschert, G.S.; Coulin, F.; Power, C.A.; Proudfoot, A.E.; Hubbard, R.E.; Hoogewerf, A.J.; Wells, T.N. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 1999, 38, 12959-12968.
47. Hoogewerf, A.J.; Kuschert, G.S.; Proudfoot, A.E.; Borlat, F.; Clark-Lewis, I.; Power, C.A.; Wells, T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997, 36, 13570-13578.
48. Fu, Y.; Kao, W.J. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin. Drug Deliv. 2010, 7, 429-444.
49. Colditz, I.; Zwahlen, R.; Dewald, B.; Baggiolini, M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am. J. Pathol. 1989, 134, 755-760.
50. Zwahlen, R.; Walz, A.; Rot, A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int. Rev. Exp. Pathol. 1993, 34B, 27-42.
51. Taub, D.D.; Anver, M.; Oppenheim, J.J.; Longo, D.L.; Murphy, W.J. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J. Clin. Investig. 1996, 97, 1931-1941.
52. Menten, P.; Wuyts, A.; van Damme, J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002, 13, 455-481.
53. Qiu, Y.; Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 2001, 53, 321-339.
54. Ahuja, S.K.; Lee, J.C.; Murphy, P.M. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. J. Biol. Chem. 1996, 271, 225-232.
55. Holmes, W.E.; Lee, J.; Kuang, W.J.; Rice, G.C.; Wood, W.I. Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253, 1278-1280.
56. Murphy, P.M.; Tiffany, H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991, 253, 1280-1283.
57. Konrad, F.M.; Reutershan, J. CXCR2 in acute lung injury. Mediat. Inflamm. 2012, 2012, 740987.
58. Ren, M.; Guo, Q.; Guo, L.; Lenz, M.; Qian, F.; Koenen, R.R.; Xu, H.; Schilling, A.B.; Weber, C.; Ye, R.D.; et al. Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. EMBO J. 2010, 29, 3952-3966.
59. Abadie, V.; Badell, E.; Douillard, P.; Ensergueix, D.; Leenen, P.J.M.; Tanguy, M.; Fiette, L.; Saeland, S.; Gicquel, B.; Winter, N. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 2005, 106, 1843-1850.
60. Maletto, B.A.; Ropolo, A.S.; Alignani, D.O.; Liscovsky, M.V.; Ranocchia, R.P.; Moron, V.G.; Pistoresi-Palencia, M.C. Presence of neutrophil-bearing antigen in lymphoid organs of immune mice. Blood 2006, 108, 3094-3102.
61. Chtanova, T.; Schaeffer, M.; Han, S.J.; van Dooren, G.G.; Nollmann, M.; Herzmark, P.; Chan, S.W.; Satija, H.; Camfield, K.; Aaron, H.; et al. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 2008, 29, 487-496.
62. Brackett, C.M.; Muhitch, J.B.; Evans, S.S.; Gollnick, S.O. IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation. J. Immunol. 2013, 191, 4348-4357.